UPDATE 1-Drug research firm PPD prices IPO at top end of target <!-- no image --> <div>Drug research firm PPD Inc said on Wednesday it raised $1.62 billion in its initial public offering (IPO) after pricing shares at the top end of its targeted range.<div class="feedflare"> <a href="http://feeds.reuters.com/~ff/reuters/UKBankingFinancial?a=znNKcMPP5jM:60ZFenKO9L4:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/reuters/UKBankingFinancial?d=yIl2AUoC8zA" border="0"></a> <a href="http://feeds.reuters.com/~ff/reuters/UKBankingFinancial?a=znNKcMPP5jM:60ZFenKO9L4:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/reuters/UKBankingFinancial?i=znNKcMPP5jM:60ZFenKO9L4:V_sGLiPBpWU" border="0"></a> <a href="http://feeds.reuters.com/~ff/reuters/UKBankingFinancial?a=znNKcMPP5jM:60ZFenKO9L4:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/reuters/UKBankingFinancial?i=znNKcMPP5jM:60ZFenKO9L4:F7zBnMyn0Lo" border="0"></a> </div><img src="http://feeds.feedburner.com/~r/reuters/UKBankingFinancial/~4/znNKcMPP5jM" height="1" width="1" alt=""></div> Posted by Reuters